WAM
PRVB

Wealthspire Advisors (Maryland)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$554K Sell
43,200
-15,000
-26% -$189K 0.02% 249
2020
Q2 		$821K Sell
58,200
-21,800
-27% -$275K 0.06% 184
2020
Q1 		$736K Buy
80,000
+10,000
+14% +$129K 0.06% 185
2019
Q4 		$1.04M Buy
70,000
+7,500
+12% +$66.8K 0.07% 162
2019
Q3 		$427K Buy
62,500
+37,500
+150% +$379K 0.03% 286
2019
Q2 		$303K Buy
+25,000
New +$136K 0.02% 347

Other funds holding PRVB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s PRVB Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) reduced its Provention Bio, Inc. Common Stock (PRVB) stake by 26% in Q3 2020, selling an estimated $189K and leaving 43,200 shares worth $554K. The position accounts for 0.02% of the portfolio, ranked #249.

Wealthspire Advisors (Maryland) first reported a position in PRVB in Q2 2019 and has held it in 6 quarters since. The position peaked at $1.04M in Q4 2019. 100 funds tracked by Wall St. Rank hold PRVB as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 43,200 shares of Provention Bio, Inc. Common Stock worth $554K as of Q3 2020.
  • Wealthspire Advisors (Maryland) sold 15,000 Provention Bio, Inc. Common Stock shares in Q3 2020, an estimated $189K.
  • Provention Bio, Inc. Common Stock made up 0.02% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #249 holding.
  • Wealthspire Advisors (Maryland) first reported a position in Provention Bio, Inc. Common Stock in Q2 2019 and has held it in 6 quarters since.
  • Wealthspire Advisors (Maryland)'s Provention Bio, Inc. Common Stock position peaked at $1.04M in Q4 2019.
  • 100 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.